Treatment responsiveness in CIDP patients with diabetes is associated with higher degrees of demyelination

Alon Abraham, Majed Alabdali, Mohammad Qrimli, Hana Albulaihe, Ari Breiner, Carolina Barnett, Hans D. Katzberg, Leif E. Lovblom, Bruce A. Perkins, Vera Bril

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Introduction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is one of several chronic treatable acquired demyelinating neuropathies. Objectives: To explore the association between the degree of demyelination in CIDP, and treatment responsiveness. Methods: A retrospective chart review of CIDP subjects assessed between 1997 and 2013 was performed to compare treatment responsiveness using different sets of criteria. Results: 99 CIDP patients were included, 34 with diabetes mellitus (DM). Treatment responsiveness was higher in CIDP-DM fulfilling 1 or more EFNS/PNS criteria, (63% vs. 31%, p = 0.03), and in CIDP+DM fulfilling 2 or more criteria (89% vs. 36%, p = 0.01). Nonetheless, treatment responsiveness in CIDP+DM had the highest odds ratio (3.73, p = 0.01). Similar results were also shown in simplified uniform study criteria, with 10% cut off values for CIDP-DM, compared to 30% for CIDP+DM. Conclusion: In CIDP+DM, higher degrees of demyelination are associated with treatment responsiveness, implying the need to adjust current criteria in these patients.

Original languageEnglish
Article numbere0139674
JournalPLoS ONE
Issue number10
StatePublished - 13 Oct 2015
Externally publishedYes


Dive into the research topics of 'Treatment responsiveness in CIDP patients with diabetes is associated with higher degrees of demyelination'. Together they form a unique fingerprint.

Cite this